Zimmer Biomet Holdings (ZBH) Cash from Financing Activities (2009 - 2026)

Zimmer Biomet Holdings has reported Cash from Financing Activities for 18 years, with the latest figure at -$369.2 million in Q1 2026.

• For the quarter ending Q1 2026, Cash from Financing Activities fell 164.16% year-over-year to -$369.2 million; the trailing twelve-month figure through Mar 2026 stood at -$618.6 million (down 538.72% YoY), and the FY2025 full-year result was $326.0 million, up 167.29% from the prior year.
• Cash from Financing Activities for Q1 2026 stood at -$369.2 million, up from -$897.0 million in the prior quarter.
• The five-year high for Cash from Financing Activities was $575.4 million in Q1 2025, with the low at -$897.0 million in Q4 2025.
• Average Cash from Financing Activities over 5 years is -$121.6 million, with a median of -$146.0 million recorded in 2022.
• Year-over-year, Cash from Financing Activities sank 415.9% in 2022 and surged 1248.5% in 2025.
• Tracing ZBH's Cash from Financing Activities over 5 years: stood at -$313.4 million in 2022, then climbed by 19.78% to -$251.4 million in 2023, then climbed by 4.3% to -$240.6 million in 2024, then tumbled by 272.82% to -$897.0 million in 2025, then jumped by 58.84% to -$369.2 million in 2026.
• The last three Cash from Financing Activities figures came in at -$369.2 million (Q1 2026), -$897.0 million (Q4 2025), and $483.8 million (Q3 2025), per Business Quant data.

Peer Comparison